PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

PHASE4CompletedINTERVENTIONAL

Enrollment

410

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Lymphoma

Interventions

DRUG

PEG-rhG-CSF

All Listed Sponsors

lead

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

INDUSTRY

NCT02805218 - PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy | Biotech Hunter | Biotech Hunter